A phospholipase A2, Laticauda colubrina phospholipase A2 II (LcPLA-II), and a phospholipase A2 homologue, Laticauda colubrina phospholipase A2 homologue I (LcPLH-I), were isolated from the venom of the yellow-lipped sea snake, Laticauda colubrina, from the Solomon Islands. LcPLA-II showed phospholipase A2 activity towards egg-yolk phosphatidylcholine (24 ,umol/min per mg at optimal conditions at 37°C) and lethal potency (LD50 45 ,ug/kg body wt. intravenously in mice). Both of the activities were lost by treatment with p-bromophenacyl bromide. LcPLH-I showed neither phospholipase A2 activity nor lethal potency at a dose of 4.5 mg/kg body wt. in mice. It was not modified by the treatment with p-bromophenacyl bromide. LcPLA-II and LcPLH-I bound Ca2+ at a 1:1 molar ratio with Kca values of 105 /LM and 44 /tM at pH 8.0 respectively. Elucidation of the amino acid sequences of these two proteins showed that each protein consisted of a single chain of 118 amino acid residues, including 14 half-cystine residues. The two sequences are different from each other at 22 residues and highly homologous to those from other sources.
INTRODUCTION
A number of phospholipases A2 (EC 3.1.1.4) have been purified, and their amino acid sequences determined, from the venoms of various snakes, including those belonging to the three families Elapidae, Colubridae and Viperidae (see reviews by Verheij et al., 1981) . Furthermore, a non-neurotoxic non-enzymic phospholipase A2 homologue, Notechis II-1, was isolated from an Australian elapid snake, Notechis scutatus scutatus , and its amino acid sequence determined (Lind & Eaker, 1980) . From a member of the sea kraits, Laticauda semifasciata, three non-neurotoxic phospholipases A2, LsPLA I, LsPLA III and LsPLA IV, were isolated (Yoshida et al., 1979) and the amino acid sequences determined (Nishida et al., 1982) .
The yellow-lipped sea snake, Laticauda colubrina, (subfamily Laticaudinae, family Elapidae), is widely distributed over a region including the Bay of Bengal, Indo-Malaysia, New Guinea, southern Japan and South Pacific islands (Smith, 1926) . The venom composition of L. colubrina varies according to the locality of the collection, and phospholipase A2 (LcPLA-II, see below) was detected so far only in the venom of L. colubrina from the Solomon Islands .
The present paper describes the isolation, properties and the complete amino acid sequences of a phospholipase A2 and its homologue from the venom of L. colubrina from the Solomon Islands.
MATERIALS AND METHODS Snake venom
The yellow-lipped sea snakes (L. colubrina) were collected in Lake Te-Nggano of Rennell Island, the Solomon Islands, in December 1980 (four specimens) and November 1981 (23 specimens). The venom was milked from the snakes, diluted with an equal volume of 0.2 M-acetic acid, brought back to the laboratory and freeze-dried. Materials Phospholipases A2 LsPLA I, LsPLA III and LsPLA IV from Laticauda semifasciata venom were purified as described previously (Yoshida et al., 1979) . Radioactive 45CaC12 (specified radioactivity 1.06 Ci/mmol) was obtained from Amersham International (Amersham, M, determination Mr determination by gel filtration was carried out with the Pharmacia f.p.l.c. system equipped with a column (1 cm x 30 cm) of Superose 12 (Pharmacia Fine Chemicals, Uppsala, Sweden) as described previously (Takasaki & Tamiya, 1985) . Chemical modification of phospholipase A2 and its homologue with p-bromophenacyl bromide Each protein (1.2 mg for LcPLA-II, 0.15 mg for LcPLH-I) was dissolved in 1.0 ml of 0.1 M-Tris/HCl buffer, pH 8.0, containing 0.1 M-NaCl and 5 mM-EDTA. To this solution was added 0.1 ml of 0.1 M-pbromophenacyl bromide solution in acetone. The reaction mixture was left for 20 h at 37°C and applied to a column (1.2 cm x 30 cm) of Sephadex G-25 equilibrated with 0.1 M-acetic acid. The protein-containing fractions were pooled and freeze-dried. Measurement of Ca2' binding Measurements of Ca2' binding to protein were performed in accordance with a modification of the equilibrium gel-filtration technique described by Pieterson et al. (1974) . A column (1.0 cm x 22 cm) of Sephadex G-50 (fine grade) was equilibrated with 50 mmTris/HCl buffer, pH 8.0, containing 0.1 M-NaCl and a known concentration of 45CaCl2 (4 x 104-8 x 104 d.p.m./ml). A 0.2 ml portion of metal-ion-free protein (approx. 1 mg) in the Ca2+-containing buffer solution was applied to the column and eluted with the same buffer. Radioactivity in the eluate was determined with a liquid-scintillation counter (model LSC-700; Aloka, Tokyo, Japan). The protein concentration of the eluate was calculated from the absorbance at 280 nm by using A2 11.0 and 8.9 for LcPLA-II and LcPLH-I respectively. The data were treated in accordance with the method of Fletcher et al. (1970) (Takasaki & Tamiya, 1982) . Automated Edman degradation with a gas-phase sequencer (model 470A; Applied Biosystems, Foster, CA, U.S.A.) was carried out essentially as described by Hewick et al. (1981) . Oxidation of LcPLA-II and LcPLH-I with performic acid LcPLA-II (75.1 mg) and LcPLH-I (28.0 mg) were separately oxidized with performic acid as described by Hirs (1956) . After 7-fold dilution the reaction mixtures were freeze-dried.
RESULTS

Isolation of phospholipase A2 and its homologue
The preliminary fractionation L. colubrina (Solomon Islands)-venom components by CM-cellulose column chromatography was described previously . Desalted fraction B (226 total A280 units) obtained from the freeze-dried venom (851 mg from 27 specimens) was applied to a column (2.2 cm x 23 cm) of CM-cellulose (Whatman CM-52) equilibrated with 0.01 M-sodium phosphate buffer, pH 5.9 (Supplementary Publication SUP 50145 Fig. 1 ). Fractions B-I and B-II, which were eluted at NaCl concentrations of 0.16 M and 0.18 M respectively, were pooled separately and freezedried. Each residue was dissolved in 0.1 M-acetic acid (15 ml) and desalted by passing through a Sephadex G-25 column (2.6 cm x 42 cm) in 0.1 M-acetic acid and freeze-dried again (yields: component B-I, 104.7 mg; component B-II, 80.5 mg). Each component was monodisperse on polyacrylamide-disc-gel electrophoresis in 7.5 % acrylamide gel at pH 4.3.
Amino acid composition
The amino acid compositions of the proteins are given in Table 1 . Each protein consisted of 118 amino acid residues. The true numbers of half-cystine residues and tyrosine residues in each protein were obtained from the sequence study.
Phospholipase A2 activity
The preparation from fraction B-Il showed in its enzymic reaction a lag period that disappeared on the addition of 1.4 mM-sodium oleate at a substrate concentration of4 mm. The enzyme activity was maximal at pH 8.2. Ca21 was required and the maximal activity was attained with 3 mM-CaCl2 in the presence of 0.7 mM-EDTA. The specific activity of the preparation from fraction B-1I measured by a titrametric method (Yoshida et al., 1979) was 24 ,mol/min per mg with egg-yolk phosphatidylcholine (4 mM) as a substrate at 37°C in the presence of 8 mM-Triton X-100, 3mM-CaCl2, 0.7 mM-EDTA and 1.4 mM-sodium oleate at pH 8.2 (Table 2) . On the other hand, the preparation from fraction B-I showed no phospholipase A2 activity in the presence or in the absence of 1.4 mM-sodium oleate and in the presence of 3 mm-or 30 mM-CaCl2. The components in fractions B-IT and B-I are named Laticauda colubrina phospholipase A2 II (LcPLA-II) and Laticauda colubrina phospholipase A2 homologue I (LcPLH-I) respectively.
Lethal potency
The lethal potency (LD50) of LcPLA-II by intravenous injection in mice (male, strain ddY, 19-21 g) was 45 jig/ kg body wt. LcPLH-I did not show lethal activity at a dose of 4.5 mg/kg body wt.
Modification of protein with p-bromophenacyl bromide
Treatment of LcPLA-II with p-bromophenacyl bromide resulted in loss of both enzymic activity and lethal potency (Table 2) . Amino acid analysis showed that LcPLA-II lost the single histidine residue whereas no other amino acid residues were affected. On the other hand the single histidine residue of LcPLH-I was not modified under the same conditions. N-Terminal amino acid sequence. Manual Edman degradation on intact performic acid-oxidized LcPLA-II (120 nmol) was performed up to the 12th step (Fig. 3) . LcPLH-I (5 nmol) with a gas-phase sequencer for 50 steps with the repetitive yield of 94.5 %. The data are shown in Supplementary Publication 50145 Table 3 . Lysyl-endopeptidase peptides. Lysyl-endopeptidase digestion of performic acid-oxidized LcPLH-I (2.8 mg) was carried out at 37°C for 5 h in 0.5 ml of 0.05 M-Tris/ HCI buffer, pH 9.1, at an enzyme/substrate ratio of 1:140 (w/w). The results of manual Edman degradation on most of the peptides are given in Fig. 4 . Chymotryptic peptides. Performic acid-oxidized LcPLH-I (3.5 mg) was digested with chymotrypsin at 37 IC for 30 min to an enzyme/substrate ratio of 1: 140 (w/w). The results of manual Edman degradation on some of the peptides are summarized in Fig. 4 .
DISCUSSION
A neurotoxic phospholipase A2, LcPLA-II, and nonenzymic, non-neurotoxic phospholipase A2 homologue, LcPLH-I, were purified from the venom of the yellowlipped sea snake, L. colubrina, from the Solomon Islands.
Their recovery was 9.5 % and 12.3 % of the crude dried venom for LcPLA-II and LcPLH-I respectively.
The amino acid sequences of LcPLA-II and LcPLH-I are given in Figs. 3 and 4. Both protein molecules are composed of 118 amino acid residues including 14 halfcystine residues.
The proteinase digestions of LcPLA-II and LcPLH-I gave, in general, the expected peptides. The peptide alignments at positions 46-47, 57-58, 80-81, 86-87 and 109-110 in the sequence of LcPLA-II and those at position 57-58 and 94-95 in the sequence of LcPLH-I were determined by the amino acid compositions of corresponding overlapping peptides. The overlapping peptide was not obtained for the positions 67-68 of LcPLA-II. Further experiments to complete the sequence of this part could not be carried out because of scarcity of the sample material. The sequence of 67-68 was deduced, however, because the sum of the amino acid compositions of the parts of 1-67 and 68-118 agrees with the amino acid composition of the whole LcPLA-II, and the N-terminal amino acid sequence of the part of 1-67 agrees with that of whole LcPLA-II. The Tyr-Asn bond (67-68) of LcPLA-II was cleaved with trypsin as well as with staphylococcal proteinase and clostripain. A similar cleavage was reported on the Tyr-Ser bond (67-68) of Pseudechis australis phospholipase A2 Pa-i 1 with trypsin, staphylococcal proteinase and carboxypeptidase Y (Nishida et al., 1985) . The tyrosyl bonds (67) (68) in phospholipases A2 may be in a conformation especially susceptible to proteinase digestion. There are two Lys-Lys bonds in the sequence of LcPLH-I. Amino acid analysis showed that lysyl-endopeptidase cleaved these Lys-Lys bonds, but not the new N-terminal lysyl bonds.
LcPLA-II showed biphasic kinetics due to activation by the reaction product (oleate). A similar observation was reported on the L. semifasciata phospholipases A2 LsPLA III and LsPLA IV (Yoshida et al., 1979) . The addition of oleate shortened the lag period without changing the highest velocity, similarly to the cases of LsPLA III and LsPLA IV. The length of lag period depended on the molar ratio of substrate (egg-yolk phosphatidylcholine) to oleate, and in the presence of 20 mol of oleate/I00 mol the lag period disappeared (results not shown). The enzymic properties of LcPLA-II were very similar to those of LsPLA III and LsPLA IV, whereas LsPLA I showed normal kinetics and had approximately 30-fold higher specific activity (Table 3) .
LsPLA I, which shows normal kinetics, can be converted into LsPLA III or LsPLA IV type with biphasic kinetics on the oxidation of Trp-64 (Yoshida et al., 1979) . LcPLA-II has Leu-64, similarly to LsPLA III or LsPLA IV. There are, however, phospholipases A2 that show normal kinetics with leucine residues at position 64 (phospholipases A2 Pa-11 and Pa-13 from Pseudechis australis venom; Nishida et al., 1985) . Therefore the 64th residue is not the only residue responsible for the biphasic kinetics.
On the other hand, only LcPLA-II, not LcPLH-I, showed the lethal activity. The three types of phospholipases A2, highly lethal and less enzymic (LcPLA-II), less lethal and highly enzymic (LsPLA I) and non-toxic and less enzymic (LsPLA III and LsPLA IV), were obtained from venoms of sea snakes of the genus Laticauda. Kondo et al. (1982) reported that Lys-58 and Lys-63 are essential for the neurotoxicity on the basis of amino acid sequence comparison of phospholipases A2. LcPLA-II has Lys-58 but not Lys-63. The carbamoylation of Lys-58 in Pa-1, however, does not affect its lethal activity (C. Takasaki, unpublished work The phospholipases A2 were obtained from: (a) and (b) Laticauda colubrina (present paper); (c) L. semifasciata (Nishida et al., 1982 ; revised by C. Takasaki, H. Kuramochi, T. Shimazu & N. Tamiya, unpublished work; (d) and (e) L. semifasciata (Nishida et al., 1982) ; (f) Enhydrina schistosa (Lind & Eaker, 1981) ; (g) Pseudechis australis (Nishida et al., 1985) ; (h) Notechis scutatus scutatus (Lind & Eaker, 1980) ; (i) N. s. scutatus (Halpert & Eaker, 1975) ; (j) Naja mossambica mossambica (Joubert, 1977) ; (k) N. melanoleuca (Joubert, 1975b) ; (1) Hemachatus haemachatus (Joubert, 1975a) ; (m) pig pancreas (Puijk et al., 1977) ; (n) bovine pancreas (Fleer et al., 1978) . The sequences were aligned with respect to the positions of the half-cystine residues.
respectively (C. Takasaki, unpublished work , and the modified enzymes lose both the enzymic and lethal activities. LcPLA-II modified at its single histidine residue (His-48) with p-bromophenacyl bromide also lost both of the activities. On the other hand, the single histidine residue in LcPLH-I (His-21) was not modified with p-bromophenacyl bromide (Table 2) .
LcPLH-I has very similar properties with respect to Mr, amino acid composition and Ca2+-binding activity to those of phospholipase A2 LcPLA-I1, but it showed neither enzymic nor lethal activities. It contains all the invariant residues present among the phospholipases A2 except for histidine-48 (Fig. 5 ). This is replaced by an asparagine residue in LcPLH-I, and the single histidine residue in the molecule is situated at position 21. This must be the reason that LcPLH-I has no enzymic activity and is not modified with p-bromophenacyl bromide. The non-enzymic homologue LcPLH-I is different in this respect from Notechis 11-1, a non-toxic and non-enzymic phospholipase A2 homologue from the Australian elapid snake Notechis scutatus scutatus described by Lind & Eaker (1980) . The latter has the invariant His-48 but has a serine residue instead ofinvariant Gly-30. It consistently accounts for 15-20 % of the weight of the dried venom. The lethality of notexin, which is the most lethal component in N. s. scutatus venom, is about the same as the crude venom itself. Lind & Eaker (1980) considered that the high lethality of the crude venom must be accountable to some kind ofsynergism, perhaps involving the 'inactive' component Notechis TI-1. On the other hand, LcPLH-I consistently accounts for 13 % of the weight of the dried venom. The main toxic components in L. colubrina venom are long-chain and short-chain post-synaptic neurotoxins named Lc a and Lc c (Tamiya et al., 1983) respectively, and the lethality in fraction B can be almost explained by the content of LcPLA-II; therefore it seems that LcPLH-I has no function on the lethality. Heinrikson et al. (1977) classified phospholipases A2 from mammalian pancreas and various snake venoms into two groups from their amino acid sequences. Group I is composed of the phospholipases A2 from pancreas and elapid venoms, whereas phospholipases A2 from crotalid and viperid venoms belong to Group II The amino acid sequences of LcPLA-II and LcPLH-I are compared with some phospholipase A2 sequences belonging to Group I (Fig. 5) . The amino acid sequences of LcPLA-II and LcPLH-I differ from each other at 22 positions out of 118 amino acid residues. LcPLA-II is homologous with phospholipases A2 from another snake of the genus, Laticauda semifasciata (73-77 %), and to some extent with those from Hydrophiinae (64 %) and Acanthopiinae (64-68 %), whereas it is less homologous with those of the other subfamily of the Elapidae, Elapinae (53-58 %). It has 44 45 % homology with the enzymes from mammalian pancreas and 34-42 % homology with
